FDA Committee Approves Vivitrol for Opioid Dependence
Links shared publicly online about this topic.
- 842total visits
FDA Committee Approves Vivitrol for Opioid Dependence
View full resource at hcplive.com
Most Recently Shared on September 27, 2010 at 8:23 pm By:
#FDA Committee Approves #Vivitrol for #Opioid Dependence http://hcp.lv/cgHOkc
Data on Vivitrol, the New FDA-Approved Medication for Prevention of Relapse to Opioid Dependence, Published in the Lancet - Drugs.com MedNews
drugs.com — “- Study Results Showed Non-Addictive, Non-Narcotic, Once-Monthly VIVITROL Effective for Treating Opioid Dependence - Apr 27, 2011 - Alkermes, Inc. (NASDAQ ALKS)” View full resource at drugs.com
Most Recently Shared on April 28, 2011 at 2:03 pm By:
Drugs and Devices OW OW Health
Data on Vivitrol, the New FDA-Approved Medication for Prevention of Relapse to Opioid Dependence, Publishe... http://bit.ly/j2jZln #drug
Data On VIVITROL(R), The New FDA-Approved Medication For Prevention Of Relapse To Opioid Dependence, Published In The Lancet
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been p” View full resource at medicalnewstoday.com
Most Recently Shared on April 28, 2011 at 12:05 pm By:
MNT Alcohol / Addict Health News
Data On VIVITROL(R), The New FDA-Approved Medication For Prevention Of Relapse To Opioid Dependence, Published In The ... http://mnt.to/3V8G
Alkermes Announces FDA Approval Of VIVITROL For Prevention Of Relapse To Opioid Dependence - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL (naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification. VIVITROL is now the first and only non-narcotic, non-addictive, once-monthly medication approved for the treatment of opioid dependence. VIVITROL was approved by the FDA in 2006 for the treatment of alcohol dependence and should be used as part of ” View full resource at qualitypointtech.net
Most Recently Shared on October 16, 2010 at 10:49 pm By:
Alkermes Announces FDA Approval Of VIVITROL® For Prevention Of Relapse To Opioid Dependence: Alkermes, Inc. (NASD... http://bit.ly/bCwk5v
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA - QualityPoint Technologies
qualitypointtech.net — “Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxification therapy. The injection is administered into the muscle (intramuscularly) once per month. Naltrexone is an opioid receptor antagonist - it blocks the brain's opioid receptors. Examples of opioids include heroin, morphine, codeine, and thebaine...” View full resource at qualitypointtech.net
Most Recently Shared on October 15, 2010 at 9:49 am By:
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA: Vivitrol (Naltrexone) in injection... http://bit.ly/aspHvY
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA
medicalnewstoday.com — “Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxificati” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2010 at 9:26 pm By:
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA Vivitrol (Naltrexone) in injection form .. http://dld.bz/z9S8
FDA Approves Vivitrol to Treat Opioid-dependent Patients
drugs.com — “Vivitrol (naltrexone) is used to treat alcohol dependence and opioid dependence. Includes Vivitrol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 13, 2010 at 11:08 pm By:
Drugs and Devices OW OW Health
FDA Approves Vivitrol to Treat Opioid-dependent Patients: ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Dr... http://bit.ly/98nTjo #drug
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.Vivitrol is an extended-” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2010 at 4:21 pm By:
MNT Alcohol / Addict Health News
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients http://mnt.to/3L8Z #alcohol #addiction
Vivitrol approved for opioid dependence - MPR
empr.com — “The FDA has approved Vivitrol (naltrexone for injection, from Alkermes) to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.” View full resource at empr.com
Most Recently Shared on October 13, 2010 at 3:43 pm By:
MPR News: Vivitrol approved for opioid dependence: The FDA has approved Vivitrol (naltrexone extended-release inje... http://bit.ly/9cWdEE
Medicine and Technology [part of HCPLive]: FDA approves Vivitrol to treat opioid-dependent patients
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA approves Vivitrol to treat opioid-dependent patients” View full resource at medicineandtechnology.com
Most Recently Shared on October 13, 2010 at 4:00 am By:
Joseph Kim, MD, MPH Physician and Doctor
FDA approves Vivitrol to treat opioid-dependent patients http://goo.gl/fb/TUJ9E
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® For Opioid Dependence
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-rele” View full resource at medicalnewstoday.com
Most Recently Shared on September 25, 2010 at 3:05 pm By:
MNT Pain News Pain Management and Health News
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® For Opioid Dependence http://mnt.to/3KmM #pain
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...” View full resource at qualitypointtech.net
Most Recently Shared on September 19, 2010 at 2:01 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence: Alkermes, Inc.... http://bit.ly/aQwbNM
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-rele” View full resource at medicalnewstoday.com
Most Recently Shared on September 19, 2010 at 1:05 pm By:
MNT Alcohol / Addict Health News
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence http://mnt.to/3JZ9 #alcohol #addiction
Pharma News: Alkermes, Arena - Forbes.com
forbes.com — “Alkermes (ALKS) said late yesterday that a FDA advisory committee voted 12 to 1 that its drug vivitrol should be approved to treat opioid dependence. The drug is currently approved to treat alcoholism.” View full resource at forbes.com
Most Recently Shared on September 17, 2010 at 6:39 pm By:
Drugs and Devices OW OW Health
Pharma News: Alkermes, Arena: Alkermes (ALKS) said late yesterday that a FDA advisory committee voted 12 to 1... http://bit.ly/aTcjUv #drug
Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence - Drugs.com MedNews
drugs.com — “Sep 16, 2010 - Alkermes, Inc. (NASDAQ ALKS) today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted” View full resource at drugs.com
Most Recently Shared on September 17, 2010 at 1:14 pm By:
Drugs and Devices OW OW Health
Alkermes Announces FDA Advisory Committee Recommends Approval of Vivitrol for Opioid Dependence: WALTHAM, Mas... http://bit.ly/awyaYT #drug
Advertisement
